PAPER Riley BE, Orr HT
SEARCH RESULTS
330712 RESULTS
PAPER Rogaeva E, Zadikoff C, Ponesse J, Schmitt-Ulms G, Kawarai T, Sato C, Salehi-Rad S, St George-Hyslop P, Lang AE
Childhood onset in familial prion disease with a novel mutation in the PRNP gene.
Arch Neurol. 2006 Jul;63(7):1016-21. PubMed: 16831973PAPER Liu Y, Ritter C, Riek R, Schubert D
The formation of bioactive amyloid species by prion proteins in vitro and in cells.
Neurosci Lett. 2006 Oct 9;406(3):200-4. PubMed: 16916580PAPER Clarke RM, O'Connell F, Lyons A, Lynch MA
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.
Neuropharmacology. 2007 Jan;52(1):136-45. PubMed: 16920163PAPER Lin H, Lin TY, Juang JL
Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration.
Cell Death Differ. 2007 Mar;14(3):607-15. PubMed: 16932754PAPER Straiko MM, Gudelsky GA, Coolen LM, Harrison R, Zemlan FP
Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain.
J Neurosci Res. 2006 Oct;84(5):1116-23. PubMed: 16917841PAPER Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sáanchez-Valle R, Mitrováa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichová D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
Neurology. 2006 Aug 22;67(4):637-43. PubMed: 16924018PAPER Sigurdson C, Polymenidou M, Aguzzi A
Reconstructing prions: fibril assembly from simple yeast to complex mammals.
Neurodegener Dis. 2005;2(1):1-5. PubMed: 16908997PAPER Kim K, Moore DH, Makriyannis A, Abood ME
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.
Eur J Pharmacol. 2006 Aug 7;542(1-3):100-5. PubMed: 16781706PAPER Millecamps S, Robertson J, Lariviere R, Mallet J, Julien JP
Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.
J Neurochem. 2006 Aug;98(3):926-38. PubMed: 16787413PAPER Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I, Standaert DG, Augood SJ, Yohrling GJ, Cha JH
Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse.
Eur J Neurosci. 2006 Jun;23(12):3171-5. PubMed: 16820007PAPER Holzbaur EL, Howland DS, Weber N, Wallace K, She Y, Kwak S, Tchistiakova LA, Murphy E, Hinson J, Karim R, Tan XY, Kelley P, McGill KC, Williams G, Hobbs C, Doherty P, Zaleska MM, Pangalos MN, Walsh FS
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis.
Neurobiol Dis. 2006 Sep;23(3):697-707. Epub 2006 Jul 11 PubMed: 16837207PAPER Xia X, Zhou H, Huang Y, Xu Z
Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.
Neurobiol Dis. 2006 Sep;23(3):578-86. PubMed: 16857362PAPER Shefner JM, Cudkowicz M, Brown RH
Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Muscle Nerve. 2006 Nov;34(5):603-7. PubMed: 16892429PAPER Ehrnhoefer DE, Duennwald M, Markovic P, Wacker JL, Engemann S, Roark M, Legleiter J, Marsh JL, Thompson LM, Lindquist S, Muchowski PJ, Wanker EE
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
Hum Mol Genet. 2006 Sep 15;15(18):2743-51. PubMed: 16893904Current Filters
- Date Range : All x